DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amevive (Alefacept) - Current Clinical Trials

 
 



Amevive Related Clinical Trials

AMEVIVE´┐Ż Pregnancy Registry [Terminated]

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Terminated]

Long-Term One Year Use of Alefacept (Amevive´┐Ż) in Moderate to Severe Chronic Plaque Type Psoriasis [Completed]

Inducing Remission in Type 1 Diabetes With Alefacept [Completed]

A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers [Completed]

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease [Terminated]

Community Based Trial for AMEVIVE« [Completed]

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation [Suspended]

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis [Completed]

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects [Completed]

A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris [Terminated]

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis [Completed]

A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients [Completed]

Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis [Completed]

Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis. [Completed]

Alefacept in Patients With Relapsed/Refractory Aplastic Anemia [Suspended]

Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy [Terminated]

Alefacept in Kidney Transplant Recipients [Withdrawn]

Safety and Tolerability of Repeat Courses of IM Alefacept [Completed]

Alefacept for Prevention of Graft Versus Host Disease (GVHD) [Terminated]

A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus [Terminated]

Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma [Active, not recruiting]

Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis [Completed]

A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis [Completed]

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate [Completed]

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis [Completed]

A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis [Completed]

Alefacept Mechanism of Action in Psoriasis [Completed]

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients [Terminated]

A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients [Completed]

Alefacept in Patients With Severe Scalp Alopecia Areata [Completed]

Transitioning From Cyclosporine to Alefacept in Psoriasis [Completed]

Alefacept for Chronic Graft Versus Host Disease [Completed]

Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis [Completed]

Safety and Tolerability of Repeat Courses of IM Alefacept [Completed]

Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis [Completed]

Psoriasis Longitudinal Assessment and Registry (PSOLAR) [Active, not recruiting]

Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015